Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy

Background— Restrictive cardiomyopathy (RCM) is a rare cardiomyopathy characterized by impaired diastolic ventricular function resulting in a poor clinical prognosis. Rarely, heritable forms of RCM have been reported, and mutations underlying RCM have been identified in genes that govern the contractile function of the cardiomyocytes. Methods and Results— We evaluated 8 family members across 4 generations by history, physical examination, electrocardiography, and echocardiography. Affected individuals presented with a pleitropic syndrome of progressive RCM, atrioventricular septal defects, and a high prevalence of atrial fibrillation. Exome sequencing of 5 affected members identified a single novel missense variant in a highly conserved residue of FLNC (filamin C; p.V2297M). FLNC encodes filamin C—a protein that acts as both a scaffold for the assembly and organization of the central contractile unit of striated muscle and also as a mechanosensitive signaling molecule during cell migration and shear stress. Immunohistochemical analysis of FLNC localization in cardiac tissue from an affected family member revealed a diminished localization at the z disk, whereas traditional localization at the intercalated disk was preserved. Stem cell-derived cardiomyocytes mutated to carry the effect allele had diminished contractile activity when compared with controls. Conclusion— We have identified a novel variant in FLNC as pathogenic variant for familial RCM—a finding that further expands on the genetic basis of this rare and morbid cardiomyopathy.

[1]  B. Candemir,et al.  Leukocyte TRP channel gene expressions in patients with non-valvular atrial fibrillation , 2017, Scientific Reports.

[2]  V. Álvarez,et al.  Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients , 2017, Circulation. Cardiovascular genetics.

[3]  L. Calò,et al.  Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. , 2016, Journal of the American College of Cardiology.

[4]  P. Ellinor,et al.  A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a. , 2016, American journal of human genetics.

[5]  J. Seidman,et al.  Single-Cell Resolution of Temporal Gene Expression during Heart Development. , 2016, Developmental cell.

[6]  X. Puente,et al.  Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C , 2016, European Journal of Human Genetics.

[7]  Kenneth L. Jones,et al.  FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy , 2016, JACC. Basic to translational science.

[8]  J. Schwartzentruber,et al.  Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy , 2016, Human Mutation.

[9]  Eduardo Kausel,et al.  Integrated Analysis of Contractile Kinetics, Force Generation, and Electrical Activity in Single Human Stem Cell-Derived Cardiomyocytes , 2015, Stem cell reports.

[10]  J. Towbin,et al.  Disturbance in Z-disk mechanosensitive proteins induced by a persistent mutant myopalladin causes familial restrictive cardiomyopathy. , 2014, Journal of the American College of Cardiology.

[11]  X. Puente,et al.  Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy , 2014, Nature Communications.

[12]  M. Marino,et al.  BLOOD AMMONIA AND GLUTAMINE AS PREDICTORS OF HYPERAMMONEMIC CRISES IN UREA CYCLE DISORDER PATIENTS , 2014, Genetics in Medicine.

[13]  Izuho Hatada,et al.  Genome engineering using the CRISPR/Cas system , 2014 .

[14]  Paul M. K. Gordon,et al.  Titin mutation in familial restrictive cardiomyopathy. , 2014, International journal of cardiology.

[15]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[16]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[17]  Robert H. Brown,et al.  Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. , 2011, American journal of human genetics.

[18]  M. Ramsby,et al.  Differential detergent fractionation of eukaryotic cells. , 2011, Cold Spring Harbor protocols.

[19]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[20]  Jana Marie Schwarz,et al.  MutationTaster evaluates disease-causing potential of sequence alterations , 2010, Nature Methods.

[21]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[22]  I. Ferrer,et al.  In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy , 2009, European Journal of Human Genetics.

[23]  J. Hartwig,et al.  Filamins in cell signaling, transcription and organ development. , 2010, Trends in cell biology.

[24]  Margaret L. Karst,et al.  Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology , 2008, Clinical genetics.

[25]  N. Sebire,et al.  Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes , 2008, Heart.

[26]  M. Simoons,et al.  Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies. , 2007, European heart journal.

[27]  M. Vorgerd,et al.  The pathomechanism of filaminopathy: altered biochemical properties explain the cellular phenotype of a protein aggregation myopathy. , 2007, Human molecular genetics.

[28]  Luis Vidali,et al.  Filamin A (FLNA) is required for cell–cell contact in vascular development and cardiac morphogenesis , 2006, Proceedings of the National Academy of Sciences.

[29]  L. Kunkel,et al.  Loss of FilaminC (FLNc) Results in Severe Defects in Myogenesis and Myotube Structure , 2006, Molecular and Cellular Biology.

[30]  S. Cross,et al.  Cardiac malformations and midline skeletal defects in mice lacking filamin A. , 2006, Human molecular genetics.

[31]  Stefan Eulitz,et al.  Unusual splicing events result in distinct Xin isoforms that associate differentially with filamin c and Mena/VASP. , 2006, Experimental cell research.

[32]  Hanns Lochmüller,et al.  A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. , 2005, American journal of human genetics.

[33]  N. Laing,et al.  A new dominant distal myopathy affecting posterior leg and anterior upper limb muscles , 2005, Neurology.

[34]  G. Blanco,et al.  Filamin C interacts with the muscular dystrophy KY protein and is abnormally distributed in mouse KY deficient muscle fibres. , 2004, Human molecular genetics.

[35]  P. Elliott,et al.  Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. , 2003, The Journal of clinical investigation.

[36]  A. Goette,et al.  Atrial Amyloidosis: An Arrhythmogenic Substrate for Persistent Atrial Fibrillation , 2002, Circulation.

[37]  S. Kempa,et al.  Indications for a Novel Muscular Dystrophy Pathway , 2000, The Journal of cell biology.

[38]  Simon C Watkins,et al.  Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein , 2000 .

[39]  J. Nagle,et al.  Missense mutations in desmin associated with familial cardiac and skeletal myopathy , 1998, Nature Genetics.

[40]  K. Pollard,et al.  Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.

[41]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[42]  Claude-Alain H. Roten,et al.  Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..

[43]  J. Beckmann,et al.  Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans. , 2003, Muscle & nerve.